Robust IPO activity in September 2026, including multiple priced deals such as American Savings Bank of Hawaii ($129 million) and Haymaker Acquisition V SPAC ($250 million) on September 16, alongside scheduled offerings like Electra Therapeutics and Holtec Nuclear Corp. later in the week, reflects sustained market access. The 2026 rebound—fueled by the record SpaceX listing earlier in the year, Nasdaq Composite gains exceeding 35% year-to-date, and supportive monetary policy—has broadened the calendar with filings across biotech, insurance, and infrastructure sectors. Trader consensus on near-certain resolution before year-end incorporates the dense pipeline of traditional and SPAC issuances, though last-minute regulatory or macroeconomic shifts could still influence timing.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於Mistral AI raises €3 billion at €20 billion valuation, plans IPO after 2026
Mistral AI drops to 5%5%
Mistral AI closed a €3 billion funding round in mid-2026 at a €20 billion valuation, nearly doubling its previous valuation. The company confirmed IPO plans but indicated the listing would likely occur after 2026, focusing on scaling and strategic partnerships in the meantime.
































警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions